Business Context and Reporting Period
Company: MEDICINOVA INC
Filing Type: Form 8-K (Current Report)
Date of Report: December 1, 2011
Reporting Period: The filing addresses events occurring on December 1, 2011, with effective dates for accounting changes on December 2, 2011.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and accounting firm changes.
Material Changes
- Dismissal of Independent Accountant: The Audit Committee approved the dismissal of KPMG LLP as the independent registered public accounting firm, effective December 2, 2011.
- Engagement of New Accountant: The Audit Committee approved the engagement of Ernst & Young LLP (E&Y) as the new independent registered public accounting firm, effective December 2, 2011.
- Audit History: KPMG's audit reports for the years ended December 31, 2010, and 2009 contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, scope, or accounting principles.
- Disagreements: There were no disagreements with KPMG on accounting principles, practices, or auditing scope during the relevant periods.
Outlook, Risks, and Contingencies
- Material Weakness in Internal Controls: The filing discloses a material weakness in internal control over financial reporting. In the third quarter of 2010, management identified control overrides and policy deviations by a senior executive officer.
- Remediation: The Company has implemented a remediation plan with the assistance of a third party.
- Consultations with New Accountant: No consultations occurred with E&Y regarding accounting principles or reportable events prior to their engagement.
Investor Verification Checklist
- Verify the status of the remediation plan for the material weakness in internal controls identified in Q3 2010.
- Review the attached letter from KPMG (Exhibit 16.1) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor future filings for the transition of audit responsibilities from KPMG to E&Y and any impact on the audit timeline for the 2011 fiscal year.
- Confirm that no further undisclosed disagreements or reportable events exist between the Company and KPMG.